These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32060406)

  • 21. Modulation of cereblon levels by anti-myeloma agents.
    Díaz-Rodríguez E; Pandiella A
    Leuk Lymphoma; 2016; 57(1):167-76. PubMed ID: 25860244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
    Noll JE; Vandyke K; Hewett DR; Mrozik KM; Bala RJ; Williams SA; Kok CH; Zannettino AC
    J Hematol Oncol; 2015 Oct; 8():106. PubMed ID: 26445238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
    Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
    Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway.
    Fan Y; Zhan Q; Xu H; Li L; Li C; Xiao Q; Xiang S; Hui T; Xiang T; Ren G
    Biochem Biophys Res Commun; 2016 Jun; 474(4):660-666. PubMed ID: 27150632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics in multiple myeloma: From mechanisms to therapy.
    Alzrigat M; Párraga AA; Jernberg-Wiklund H
    Semin Cancer Biol; 2018 Aug; 51():101-115. PubMed ID: 28962927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
    Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
    Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
    Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
    J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma.
    Damgaard T; Knudsen LM; Dahl IM; Gimsing P; Lodahl M; Rasmussen T
    Leuk Lymphoma; 2009 Feb; 50(2):236-46. PubMed ID: 19235015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.
    Handa H; Kuroda Y; Kimura K; Masuda Y; Hattori H; Alkebsi L; Matsumoto M; Kasamatsu T; Kobayashi N; Tahara KI; Takizawa M; Koiso H; Ishizaki T; Shimizu H; Yokohama A; Tsukamoto N; Saito T; Murakami H
    Br J Haematol; 2017 Nov; 179(3):449-460. PubMed ID: 28770558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma.
    Di Martino MT; Guzzi PH; Caracciolo D; Agnelli L; Neri A; Walker BA; Morgan GJ; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2015 Aug; 6(22):19132-47. PubMed ID: 26056083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment.
    Gu C; Feng L; Peng H; Yang H; Feng Z; Yang Y
    Oncotarget; 2016 Jan; 7(4):4559-69. PubMed ID: 26683226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma.
    Cottini F; Hideshima T; Suzuki R; Tai YT; Bianchini G; Richardson PG; Anderson KC; Tonon G
    Cancer Discov; 2015 Sep; 5(9):972-87. PubMed ID: 26080835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6-induced Bcl6 variant 2 supports IL-6-dependent myeloma cell proliferation and survival through STAT3.
    Tsuyama N; Danjoh I; Otsuyama K; Obata M; Tahara H; Ohta T; Ishikawa H
    Biochem Biophys Res Commun; 2005 Nov; 337(1):201-8. PubMed ID: 16188230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.
    Krzeminski P; Corchete LA; García JL; López-Corral L; Fermiñán E; García EM; Martín AA; Hernández-Rivas JM; García-Sanz R; San Miguel JF; Gutiérrez NC
    Oncotarget; 2016 Dec; 7(49):80664-80679. PubMed ID: 27811368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
    Hudlebusch HR; Theilgaard-Mönch K; Lodahl M; Johnsen HE; Rasmussen T
    Br J Haematol; 2005 Sep; 130(5):700-8. PubMed ID: 16115125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards Stratified Medicine in Plasma Cell Myeloma.
    Egan P; Drain S; Conway C; Bjourson AJ; Alexander HD
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of methylation pattern in multiple myeloma.
    San-Miguel J; García-Sanz R; López-Pérez R
    Acta Haematol; 2005; 114 Suppl 1():23-6. PubMed ID: 16166769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevant prognostic features of multiple myeloma and the new International Staging System.
    Gertz MA
    Leuk Lymphoma; 2007 Mar; 48(3):458-68. PubMed ID: 17454585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
    Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
    Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.
    Zheng JF; Guo NH; Zi FM; Cheng J
    Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31712391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.